Total Payments
$33,082
2024 Payments
$3,696
Companies
90
Transactions
1,495
Medicare Patients
23,303
Medicare Billing
$4.3M
Payment Breakdown by Category
Food & Beverage$23,995 (72.5%)
Consulting$5,400 (16.3%)
Travel$1,768 (5.3%)
Education$1,368 (4.1%)
Other$550.00 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,995 | 1,454 | 72.5% |
| Consulting Fee | $5,400 | 2 | 16.3% |
| Travel and Lodging | $1,768 | 5 | 5.3% |
| Education | $1,368 | 33 | 4.1% |
| Honoraria | $550.00 | 1 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $5,921 | 107 | $0 (2024) |
| Heron Therapeutics, Inc. | $3,636 | 8 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $2,129 | 123 | $0 (2024) |
| Janssen Biotech, Inc. | $1,970 | 129 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,856 | 153 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,779 | 115 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,410 | 82 | $0 (2024) |
| Daiichi Sankyo Inc. | $1,074 | 27 | $0 (2024) |
| PFIZER INC. | $1,028 | 63 | $0 (2024) |
| GENZYME CORPORATION | $953.56 | 50 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,696 | 184 | Novartis Pharmaceuticals Corporation ($535.66) |
| 2023 | $3,420 | 176 | Novartis Pharmaceuticals Corporation ($329.82) |
| 2022 | $3,846 | 193 | Daiichi Sankyo Inc. ($613.35) |
| 2021 | $3,445 | 202 | NOVARTIS PHARMACEUTICALS CORPORATION ($362.28) |
| 2020 | $2,358 | 139 | Janssen Biotech, Inc. ($371.38) |
| 2019 | $3,247 | 207 | Genentech USA, Inc. ($463.85) |
| 2018 | $2,572 | 177 | Janssen Biotech, Inc. ($292.76) |
| 2017 | $10,497 | 217 | Genentech USA, Inc. ($4,504) |
All Payment Transactions
1,495 individual payment records from CMS Open Payments — Page 1 of 60
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $19.68 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/12/2024 | Pharmacosmos Therapeutics Inc. | COSELA (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: HEMATOLOGY | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | Organogenesis Inc. | PURAPLY FRANCHISE (Device) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: WOUND CARE | ||||||
| 12/06/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $8.95 | General |
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $15.82 | General |
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $15.27 | General |
| Category: Oncology | ||||||
| 11/25/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug), TGCT | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/16/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: DESMOID TUMORS | ||||||
| 11/13/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $12.81 | General |
| Category: Oncology | ||||||
| 11/07/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Genentech USA, Inc. | Itovebi (Biological) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: BioOncology | ||||||
| 11/01/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: ONCOLOGY | ||||||
| 10/26/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $74.39 | General |
| 10/26/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $67.97 | General |
| Category: Oncology | ||||||
| 10/24/2024 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $101.93 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Oncology | ||||||
| 10/18/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 73 | 6,559 | 185,510 | $4.1M | $1.4M |
| 2022 | 72 | 5,930 | 182,390 | $4.4M | $1.4M |
| 2021 | 63 | 5,545 | 145,238 | $2.5M | $747,407 |
| 2020 | 58 | 5,269 | 130,565 | $2.6M | $738,941 |
Total Patients
23,303
Total Services
643,703
Medicare Billing
$4.3M
Procedure Codes
266
All Medicare Procedures & Services
266 procedure records from CMS Medicare Utilization — Page 1 of 11
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 15 | 13,800 | $1.4M | $595,891 | 41.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 115 | 16,440 | $764,400 | $299,836 | 39.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 393 | 680 | $177,760 | $60,622 | 34.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 147 | 547 | $386,200 | $49,250 | 12.8% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2023 | 28 | 16,775 | $100,650 | $39,654 | 39.4% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 39 | 45,000 | $90,000 | $39,621 | 44.0% |
| J1437 | Injection, ferric derisomaltose, 10 mg | Office | 2023 | 14 | 1,500 | $82,500 | $24,809 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 341 | 419 | $65,205 | $23,666 | 36.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 97 | 147 | $43,075 | $18,501 | 43.0% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 76 | 80 | $56,600 | $17,950 | 31.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 770 | 1,681 | $112,725 | $17,266 | 15.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 890 | 2,055 | $25,920 | $17,130 | 66.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 843 | 1,951 | $132,345 | $14,733 | 11.1% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 126 | 714 | $71,400 | $14,473 | 20.3% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 33 | 26,010 | $52,020 | $10,106 | 19.4% |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | Office | 2023 | 12 | 53 | $27,550 | $9,456 | 34.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 120 | 180 | $21,600 | $7,818 | 36.2% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 48 | 174 | $26,100 | $7,716 | 29.6% |
| J0185 | Injection, aprepitant, 1 mg | Office | 2023 | 12 | 4,940 | $19,760 | $6,752 | 34.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $22,400 | $6,319 | 28.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 11 | 48 | $21,600 | $6,001 | 27.8% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 69 | 71 | $37,350 | $5,934 | 15.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 226 | 530 | $39,750 | $5,250 | 13.2% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 29 | 82 | $28,700 | $4,258 | 14.8% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 173 | 277 | $13,850 | $3,689 | 26.6% |
About Dr. Alice David, M.D
Dr. Alice David, M.D is a Hematology & Oncology healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780661066.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alice David, M.D has received a total of $33,082 in payments from pharmaceutical and medical device companies, with $3,696 received in 2024. These payments were reported across 1,495 transactions from 90 companies. The most common payment nature is "Food and Beverage" ($23,995).
As a Medicare-enrolled provider, David has provided services to 23,303 Medicare beneficiaries, totaling 643,703 services with total Medicare billing of $4.3M. Data is available for 4 years (2020–2023), covering 266 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Augusta, GA
- Active Since 12/28/2005
- Last Updated 10/02/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1780661066
Products in Payments
- TECENTRIQ (Biological) $4,325
- SUSTOL (Drug) $3,589
- KEYTRUDA (Biological) $1,600
- OPDIVO (Biological) $1,076
- IMBRUVICA (Drug) $875.51
- LIBTAYO (Biological) $523.82
- LYNPARZA (Drug) $512.66
- KISQALI (Drug) $490.25
- DARZALEX (Biological) $487.91
- IBRANCE (Drug) $458.00
- Perjeta (Biological) $445.16
- Lenvima (Drug) $410.40
- JEVTANA (Drug) $374.77
- PROMACTA (Drug) $359.41
- Imbruvica (Drug) $329.53
- GILOTRIF (Drug) $301.73
- TAGRISSO (Drug) $299.55
- XTANDI (Drug) $297.00
- ERLEADA (Drug) $295.21
- Enhertu (Drug) $293.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Augusta
Jigarkumar Parikh, Md, MD
Hematology & Oncology — Payments: $277,634
Hematology & Oncology $277,634
Abdullah Kutlar, Md, MD
Hematology & Oncology — Payments: $210,954
Hematology & Oncology $210,954
Vamsi Kota, Md, MD
Hematology & Oncology — Payments: $180,489
Hematology & Oncology $180,489
Dr. Brent Limbaugh, M.d., Ph.d, M.D., PH.D
Hematology & Oncology — Payments: $117,413
Hematology & Oncology $117,413
Dr. Eugene Long, M.d, M.D
Hematology & Oncology — Payments: $34,623
Hematology & Oncology $34,623
Dr. Miriam Atkins, M.d, M.D
Hematology & Oncology — Payments: $33,596
Hematology & Oncology $33,596